Black Lives Matter
We stand in solidarity with those peacefully protesting
We at InVivo Biosystems would like to extend our deepest condolences to the family and loved ones of George Floyd. Now more than ever we need leadership, unity, and action to undo decades of discrimination and oppression. InVivo Biosystems stands in solidarity with those who are rightfully demanding justice for George Floyd, Breonna Taylor, Ahmaud Aubrey, and so many countless others who have died needlessly. InVivo Biosystems supports those who are peacefully protesting, and we encourage everyone to lift up their voices and work towards creating a more just, safe, and inclusive community for all.
Read the full statement and learn what we are doing
Featured Findings:
- Precise Knock-outs for Precise Research
- Knockouts are the bread and butter of reverse genetic studies. But precision can be tricky. We have made well over 300 knockout lines and want to share some of our wisdom with you.
Read more
- Knockouts are the bread and butter of reverse genetic studies. But precision can be tricky. We have made well over 300 knockout lines and want to share some of our wisdom with you.
- 17 Minutes of Science: From zebrafish to electric fish, the evolution of a PhD student’s research
- Join us as we discuss with Kassandra Ford how her undergrad work in zebrafish helped inspire her to have a career in science, the work she is doing in electric fish for her PhD research, and about representation in science and how that has impacted and inspired her.
Watch the interview
- Join us as we discuss with Kassandra Ford how her undergrad work in zebrafish helped inspire her to have a career in science, the work she is doing in electric fish for her PhD research, and about representation in science and how that has impacted and inspired her.
- Alzheimer’s awareness month [Infographic]
- June is Alzheimer’s awareness month. The major goal of Alzheimer’s research is to find therapies to treat the disease or prevent it from developing. C. elegans has emerged as a promising in vivo model for studying Alzheimer’s disease as it may be used as a tool for pharmacological evaluation of novel therapeutic agents. Learn more about Alzheimer’s Disease and why C. elegans are an effective model for studying the disease.
Read more
- June is Alzheimer’s awareness month. The major goal of Alzheimer’s research is to find therapies to treat the disease or prevent it from developing. C. elegans has emerged as a promising in vivo model for studying Alzheimer’s disease as it may be used as a tool for pharmacological evaluation of novel therapeutic agents. Learn more about Alzheimer’s Disease and why C. elegans are an effective model for studying the disease.
- 17 Minutes of Science: Using artificial intelligence and machine learning to understand physician and patient decision-making
- Join us as we talk with Briana Brownell about how artificial intelligence and machine learning can help us understand decision-making in the healthcare industry (and why that is important).
Watch the interview
- Join us as we talk with Briana Brownell about how artificial intelligence and machine learning can help us understand decision-making in the healthcare industry (and why that is important).
- Viral gene therapies and their potential use against COVID-19
- This coming week on 17 Minutes of Science we are joined by Mark Mendoza. Mark currently works at the Fred Hutch Cancer Research Center in Seattle where his work primarily focuses on gene therapies, which are currently being looked at as an option in the fight against COVID-19. Join us as we discuss with Mark Mendoza about viral gene therapies in relation to COVID-19.
RSVP
- This coming week on 17 Minutes of Science we are joined by Mark Mendoza. Mark currently works at the Fred Hutch Cancer Research Center in Seattle where his work primarily focuses on gene therapies, which are currently being looked at as an option in the fight against COVID-19. Join us as we discuss with Mark Mendoza about viral gene therapies in relation to COVID-19.
Industry News:
- 23andMe says it’s ‘part of the problem’ on racial inequity. We asked geneticists what the company can do about it
- FDA approves first drug to image Tau pathology in patients being evaluated for Alzheimer’s disease
- Pfizer breakthrough growth initiative
- Lilly begins world’s first study of a potential COVID-19 antibody treatment in humans
- New gene therapy technique shows promise in stem cell model of retinitis pigmentosa
P.S.
Need some new wall decor for you lab? Sammy Katta has created a set of beautiful diversity and inclusion lab posters that are free to download and print. Check them out.
